Interested in learning more about Minnesota Biomanufacturing Services and our capabilities? Here a few frequently asked questions from potential clients.
How do I contact MBS?
Email and phone contact information are on the staff and contact section of the website.
Can I tour the MBS facility?
How much will my project cost? Do you have standard rates for each fermenter scale?
We do not have standard rates for each fermentation scale. Because each project’s production conditions are unique, each project is priced based on the project’s run details.
I need a cost estimate for budgeting purposes but don’t have enough time to put a CDA in place so that a formal quote can be generated. Can you provide a ballpark cost estimate?
Yes. We are usually able to provide a rough non-binding estimate of pricing based only on non-confidential discussions. However, we are not able to provide a formal quote without a detailed discussion for which clients usually require a CDA.
How long will it take for my project to start?
Once a services agreement has been signed, your project will be formally added to the production schedule. The lead time typically ranges from 1–4 months.
Is it necessary to have a signed contract in place before my project is put on the production schedule?
Yes. While we do our best to plan for projects while they are still in contract negotiation, it is required to have a signed services agreement before a project is formally entered into the production schedule.
Can I observe my production run?
Yes, you are welcome to visit MBS while your batch is being produced. Due to client confidentiality, it is necessary to request and receive permission to visit in advance.
Are MBS manufacturing operations carried out under cGMPs?
Due to facility and personnel limitations, MBS' production operations are not cGMP-compliant. However, our quality system is based on FDA, EU, and ICH cGMP guidelines, and is routinely audited by both clients and external quality consultants.
Does MBS do mammalian cell culture projects?
No. At this time, the MBS facility and equipment capabilities cannot accommodate mammalian cell culture projects.